11th Alzheimer’s & Parkinson’s Drug Development
congress program
Location : San Francisco
Country : United States
Language : ENG
Start :
End :
https://alzheimers-parkinsons-summit.com/
Specialities : Geriatrics , Neurology
Heading to sunny San Francisco for the first time, the 11th Alzheimer’s & Parkinson’s Drug Development Summit is the only-industry-focused event dedicated to overcoming the challenges and showcasing the opportunities of targeting Alzheimer’s and Parkinson’s Disease.
Previously known as the Neurodegenerative Drug Development Summit, don’t miss your only opportunity to hear about the latest clinical pipeline progressions in 2022, learn new insights into neurodegenerative disease mechanisms for new target identification, explore the latest advances in neurological biomarkers and how to incorporate them into clinical trials successfully, and discover the next generation in-vitro and in-vivo preclinical models for safety and efficacy testing.
Selected conferences
18 ème Congrès National de l'Animation et de l'Accompagnement Gérontologique CNAAG 2024
- Date : 2024-11-26
-
4270
0